Use Of Pde Iii Inhibitors Or Calcium Sensitizers For The Treatment Of Asymptomatic (Occult) Heart Failure

Patent No. EP1951227 (titled "Use Of Pde Iii Inhibitors Or Calcium Sensitizers For The Treatment Of Asymptomatic (Occult) Heart Failure") was filed by Boehringer Ingelheim on Nov 8, 2006. The application was issued on Apr 12, 2017.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
VIRBACJan 12, 2018GEVERS & ORES

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1951227

BOEHRINGER INGELHEIM
Application Number
EP06829958A
Filing Date
Nov 8, 2006
Status
Opposition Rejected
Jun 28, 2019
Publication Date
Apr 12, 2017